CD44 and non-small cell lung carcinoma: Interestingly, in our NSCLC group treated with curative intent, a joint effect of OPN rs11730582 and CD44 rs187116 on the risk of developing metastases was also observed, while each of them individually showed no significant influence on MFS, which indicates the need to take multiple SNPs into account for risk stratification.